Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction

Journal of Clinical Oncology

Volumn 32, Issue 27, 2014, Pages 2983-2990

  Davies, Andrew R ^a,b,d   Gossage, James A ^a,b,d   Zylstra, Janine ^a,b,d   Mattsson, Fredrik ^d   Lagergren, Jesper ^a,b,d   Maisey, Nick ^a   Smyth, Elizabeth C ^b,c   Cunningham, David ^b,c   Allum, William H ^c   Mason, Robert C ^a,b,d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; EPIRUBICIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONSENSUS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; SCORING SYSTEM; TREATMENT RESPONSE; TUMOR DIFFERENTIATION; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CLINICAL TRIAL; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; FACTUAL DATABASE; KAPLAN MEIER METHOD; LOWER ESOPHAGUS SPHINCTER; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; STOMACH NEOPLASMS; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONDON; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84907190376     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.9070     Document Type: Article

References (23)

1. Cunningham D, Allum WH, Stenning S.P., et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
2. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without pre-operative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 359:1727-1733, 2002
3. Ychou M, Boige V, Pignon J.P., et al.: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715-1721, 2011
4. Sujendran V, Wheeler J, Baron R., et al.: Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg 95:191-194, 2008
5. Matsuyama J, Doki Y, Yasuda T., et al.: The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus. Surgery 141:570-580, 2007
6. Siewert JR, Stein HJ: Classification of adeno-carcinoma of the oesophagogastric junction. Br J Surg 85:1457-1459, 1998
7. Rice TW, Blackstone EH, Rusch VW: 7th edition of the AJCC Cancer Staging Manual: Esophagus and esophagogastric junction. Ann Surg Oncol 17:1721-1724, 2010
8. Mandard AM, Dalibard F, Mandard J.C., et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: Clinicopathologic correlations. Cancer 73: 2680-2686, 1994
9. Cunningham D, Starling N, Rao S., et al.: Cape-citabine and oxaliplatin for advanced esophagogas-tric cancer. N Engl J Med 358:36-46, 2008
10. Mapstone N: Dataset for the Histopathological Reporting of Oesophageal Carcinoma (ed 2). London, United Kingdom, Royal College of Pathologists, 2007
11. van Hagen P, Hulshof MC, van Lanschot JJ, et al.: Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074-2084, 2012
12. Davies AR, Sandhu H, Pillai A., et al.: Surgical resection strategy and the influence of radicality on outcomes in oesophageal cancer. Br J Surg 101: 511-517, 2014
13. Ngamruengphong S, Sharma VK, Nguyen B, et al.: Assessment of response to neoadjuvant therapy in esophageal cancer: An updated systematic review of diagnostic accuracy of endo-scopic ultrasonography and fluorodeoxyglucose positron emission tomography. Dis Esophagus 23:216-231, 2010
14. Stahl M, Walz MK, Stuschke M, et al.: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009
15. Bonavina L, Soligo D, Quirici N., et al.: Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 129: 15-22, 2001
16. Peyre CG, Hagen JA, DeMeester S.R., et al.: Predicting systemic disease in patients with esoph-ageal cancer after esophagectomy: A multinational study on the significance of the number of involved lymph nodes. Ann Surg 248:979-985, 2008
17. Davies AR, Pillai A, Sinha P., et al.: Factors associated with early recurrence and death after esophagectomy for cancer. J Surg Oncol 109:459-464, 2014
18. van Hagen P, Wijnhoven BP, Nafteux P, et al.: Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradio-therapy and surgery for oesophageal cancer. Br J Surg 100:267-273, 2013
19. Li SH, Wang Z, Liu X.Y., et al.: Lymph node micro-metastasis: A predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 37:1047-1052, 2007
20. Buskens CJ, Ten Kate FJ, Obertop H, et al.: Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarci-noma of the distal esophagus or gastric cardia. Dis Esophagus 21:488-495, 2008
21. Prenzel KL, Hölscher AH, Drebber U., et al.: Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol 38:314-318, 2012
22. Izbicki JR, Hosch SB, Pichlmeier U, et al.: Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337:1188-1194, 1997
23. Spence GM, Graham AN, Mulholland K, et al.: Bone marrow micrometastases and markers of an-giogenesis in esophageal cancer. Ann Thorac Surg 78:1944-1949, 2004